creat bluematrix
solid start expect result push
oper result across divis combin oper result
greater expect share repurchas elimin loss
pharmedium go forward contribut ep guidanc rais consid
somewhat disappoint compani sell pharmedium believ
elimin busi make invest thesi cleaner go forward expect
result well receiv investor push share higher today trade
bottom line result across compani divis pharmaceut distribut
strong compani rais outlook oper profit
busi suggest us volum drug price inflation/defl
trend least line manag forecast manag repurchas
share expect lower fy share count guidanc share
 estim contribut guidanc rais see guidanc
detail big news quarter manag final came decis
pharmedium decid exit busi ceas oper given
busi gener oper loss look call see
much decis may benefit full year outlook disappoint
compani could find buyer asset press releas state compani get
cash tax benefit next three fiscal year cash tax
benefit closur busi benefit alreadi rock solid balanc sheet
net debt expect result decis exit
pharmedium guidanc rais well receiv push share higher
highlight quarter
adjust oper incom consensu beat
larg driven pharmaceut distribut busi
adjust ep consensu
total revenu line consensu
adjust gross profit line consensu
compani shut pharmedium busi expect realiz cash
tax benefit
rais guidanc total oper incom growth pharmaceut distribut
oper incom growth adjust ep driven strong result share
repurchas exit pharmedium busi
compani offer follow updat guidanc
rais dilut ep vs previous
driven strong result core pharmaceut distribut segment lower share
count expect elimin loss pharmedium remaind
year expect detail relat pharmedium call
page analyst certif import disclosur
rais pharmaceut distribut oper incom growth msd vs lsd-msd rang
revenu growth msd-hsd rang
oper expens msd
adjust oper incom growth guidanc lsd-msd rang
oper incom growth hsd rang
lower weight averag dilut share count vs previous
adjust free cash flow
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst whose name appear report receiv compens base upon variou factor includ qualiti research
investor client feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic
corpor next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori amerisourcebergen corpor
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
equiti valuat risk valuat methodolog risk associ cover compani price target cover compani pleas
see recent company-specif research report http //guggenheimlibrari bluematrix com/client/librari jsp contact primari analyst
guggenheim secur llc repres email
